Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ECCO 15 - ESMO 34 /
Current situation with aromatase inhibitors

20th - 24th Sep 2009

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.11.09
Views: 16690

Prof Charles Coombes - Imperial College School of Medicine, London, UK

Prof Charles Coombes of the Imperial College School of Medicine, London, UK, speaking at ECCO 15 - ESMO 34, Sept 2009, Berlin: Current situation with aromatase inhibitors. Increase in disease free survival. Comparison with Tamoxifen, bisphosphonates.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation